A cut-off value of plasma osteoprotegerin level may predict the presence of coronary artery calcifications in chronic kidney disease patients
Authors:
- Marion MorenaMMMarion Morena
- Anne-Marie DupuyADAnne-Marie Dupuy
- Bernard CanaudBCBernard Canaud
- Jean-Paul CristolJCJean-Paul Cristol
Open Access
- 2 July 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 24 (11) , 3389-3397
Abstract
Background. Expression of bone proteins resulting from transdifferentiation of vascular smooth muscle cells into osteoblasts suggests that vascular calcifications are a bioactive process. Osteoprotegerin (OPG) could play a key role in bone-vascular calcification imbalance and could be a marker of vascular calcification extent and progression. The purpose of this study was to evaluate relationships between vascular risk biomarkers (including classic risk factors and OPG) and coronary artery calcification (CAC) extent in chronic kidney disease (CKD) patients and to establish within the markers the appropriate cut-off value to predict CAC. Methods. A total of 133 non-dialyzed CKD patients at various stages of kidney disease [75 males/58 females, median age: 69.9 (27.4–94.6)] were enrolled, excluding extrarenal replacement therapy patients. All underwent chest multidetector computed tomography for CAC scoring. Blood samples were collected for measurement of vascular risk markers (kidney disease, inflammation, nutrition, calcium phosphate and OPG). A potential relationship between CAC and these biological markers was investigated, and a receiver-operating characteristic (ROC) curve was designed thereafter to identify a cut-off value of involved markers that best predicted the presence of CAC. Results. After adjustment for age, diabetes, smoking and gender, among biological markers, only low-estimated glomerular filtration rate using Modification of Diet in Renal Disease [OR = 3.63 (1.10–12.02)], high FEPO 4 [OR = 3.99 (1.17–13.6)] and high OPG levels [OR = 8.54 (2.14–34.11)] were associated with the presence of CAC. A protective effect of 1.25(OH) 2 vitamin D [OR = 0.20 (0.05–0.79)] and LDL cholesterol [OR = 0.27 (0.08–0.94)] on CAC was also observed. ROC curve analysis showed that the OPG best cut-off value predicting CAC was 757.7 pg/mL. Conclusion. These results suggest that a CAC increase is strongly associated with a plasma OPG increase in CKD patients. The values of OPG >757.7 pg/mL allow us to predict the presence of CAC in these patients.Keywords
This publication has 48 references indexed in Scilit:
- Reducing the Burden of Cardiovascular Calcification in Patients with Chronic Kidney DiseaseJournal of the American Society of Nephrology, 2005
- Coronary artery calcification in patients with CRF not undergoing dialysisAmerican Journal of Kidney Diseases, 2004
- Regulation of Vascular Calcification by Osteoclast Regulatory Factors RANKL and OsteoprotegerinCirculation Research, 2004
- Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortalityNephrology Dialysis Transplantation, 2003
- Cardiovascular Calcifications in Uremic PatientsJournal of the American Society of Nephrology, 2003
- Increased Osteoprotegerin Serum Levels in Men with Coronary Artery DiseaseThe Journal of Clinical Endocrinology & Metabolism, 2003
- Cardiac calcification in adult hemodialysis patientsJACC, 2002
- Differential Expression of Bone Matrix Regulatory Proteins in Human Atherosclerotic PlaquesArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Associations of Serum Osteoprotegerin Levels with Diabetes, Stroke, Bone Density, Fractures, and Mortality in Elderly WomenThe Journal of Clinical Endocrinology & Metabolism, 2001
- Coronary-Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing DialysisNew England Journal of Medicine, 2000